ES2053692T3 - Compuestos triciclicos. - Google Patents

Compuestos triciclicos.

Info

Publication number
ES2053692T3
ES2053692T3 ES88120889T ES88120889T ES2053692T3 ES 2053692 T3 ES2053692 T3 ES 2053692T3 ES 88120889 T ES88120889 T ES 88120889T ES 88120889 T ES88120889 T ES 88120889T ES 2053692 T3 ES2053692 T3 ES 2053692T3
Authority
ES
Spain
Prior art keywords
formula
hydrogen
link
independently
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88120889T
Other languages
English (en)
Inventor
Etsuo Oshima
Hiroyuki Obase
Akira Karasawa
Kazuhiro Kubo
Ichiro Miki
Akio Ishii
Hidee Ishii
Kenji Ohmori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2053692T3 publication Critical patent/ES2053692T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPONENTES TRICICLICOS REPRESENTADOS POR LA FORMULA (1), EN DONDE REPRESENTA ENLACE SIMPLE O DOBLE; X1-X2 REPRESENTA -CH2O- EN DONDE REPRESENTA 0,1 O 2, -CH2-CH2-, O, -CH=CH-; W REPRESENTA -S- O =CH-; N ES 1,2,3 O 4; UNO DE RA Y RB REPRESENTA HIDROGENO Y EL OTRO REPRESENTA -Y-M EN DONDE Y REPRESENTA UN ENLACE SIMPLE, -CR1R2-(CH2)M-, O, -CR1=CR2-(CH2)M EN DONDE CADA UNO DE R1 Y R2 REPRESENTAN INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR Y M ES 0,1,2,3 O 4, EN EL CUAL, EL LADO IZQUIERDO DE CADA FORMULA ES ENLAZADO AL NUCLEO MADRE; Y M REPRESENTA -COOR3 EN DONDE R3 REPRESENTAN HIDROGENO O ALQUILO INFERIOR, -CONR3AR3B EN DONDE CADA UNO DE R3A Y R3B TIENE INDEPENDIENTEMENTE EL MISMO SIGNIFICADO PARA R3 DESCRITO ANTERIORMENTE, O TETRAZOLIL; CADA UNO DE GA Y GB REPRESENTAN INDEPENDIENTEMENTE ALQUILO INFERIOR, HALOGENO, HIDROXILO O ALCOXILO INFERIOR; CADA UNO DE GA Y GB REPRESENTAN INDEPENDIENTEMENTE 0,1,2 O 3; Z REPRESENTA N-E1-Q EN DONDE E1 REPRESENTA UN ENLACE SIMPLE, -CO-, -COO EN DONDE ELLADO IZQUIERDO DE LA FORMULA ES ENLAZADO AL ATOMO DE NITROGENO, O -SO2; Y Q REPRESENTA ASIL, ARALQUIL, ARALQUENIL OPCIONALMENTE SUSTITUIDOS, UN GRUPO HETEROCICLICO AROMATICO, O FORMULA (2): EN DONDE L REPRESENTA HIDROGENO, HIDROXIDO, O ALCOXI INFERIOR; E2 REPRESENTA UN ENLACE SIMPLE, -CO-, O EN DONDE R4 REPRESENTA HIDROGENO O ALQUILO INFERIOR; Y Q TIENE LA MISMA SIGNIFICACION QUE SE DESCRIBE ANTERIORMENTE; C=CH-Q EN DONDE Q TIENE LA MISMA SIGNIFICACION ANTERIOR; O FORMULA (3): P ES 1,2 O 3; POSEE UNA POTENTE ACCION ANTAGONICA CONTRA EL TROMBOXANO A2 Y TAMBIEN UNA ACTIVIDAD ANTIALERGICA Y/O ANTIHISTAMINICA, Y ESTAN DESTINADOS A TENER EFECTOS PREVENTIVOS Y TERAPEUTICOS SOBRE ENFERMEDADES ISTERMICAS, CEREBRO-VASCULARES, ETC.
ES88120889T 1987-12-14 1988-12-14 Compuestos triciclicos. Expired - Lifetime ES2053692T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31576987 1987-12-14
JP2354388 1988-02-03

Publications (1)

Publication Number Publication Date
ES2053692T3 true ES2053692T3 (es) 1994-08-01

Family

ID=26360920

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88120889T Expired - Lifetime ES2053692T3 (es) 1987-12-14 1988-12-14 Compuestos triciclicos.

Country Status (5)

Country Link
US (3) US4994463A (es)
EP (1) EP0325755B1 (es)
AU (1) AU612437B2 (es)
DE (1) DE3888821T2 (es)
ES (1) ES2053692T3 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES524680A0 (es) * 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
AU605501B2 (en) * 1987-08-25 1991-01-17 Kyowa Hakko Kirin Co., Ltd. Dibenz(b,e)oxepin derivative and antiallergic agent
CA1338625C (en) * 1988-06-09 1996-10-01 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
CA2217194A1 (en) * 1995-04-07 1996-10-10 Novo Nordisk A/S Novel heterocyclic compounds
WO1996031503A1 (en) * 1995-04-07 1996-10-10 Novo Nordisk A/S Novel heterocyclic compounds
DK0910563T3 (da) * 1995-06-29 2003-09-01 Smithkline Beecham Corp Integrinreceptorantagonister
US6008213A (en) * 1995-06-29 1999-12-28 Smithkline Beecham Corporation Integrin receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP0920306A2 (en) 1996-07-12 1999-06-09 Leukosite, Inc. Chemokine receptor antagonists and methods of use therefor
KR20000048899A (ko) * 1996-10-04 2000-07-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 1,4-디치환 피페라진
CN1099416C (zh) * 1996-12-28 2003-01-22 史密丝克莱恩比彻姆公司 整联蛋白受体拮抗剂
CO4920232A1 (es) * 1997-01-08 2000-05-29 Smithkline Beecham Corp Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin
WO1999037619A1 (en) 1998-01-21 1999-07-29 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
IL137266A0 (en) 1998-01-21 2001-07-24 Millennium Pharm Inc Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) * 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP1547616A1 (en) * 2002-08-22 2005-06-29 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic drugs for itch
AU2003262229A1 (en) * 2002-08-22 2004-03-11 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic drugs for asthma
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2004093912A1 (ja) * 2003-04-23 2004-11-04 Kyowa Hakko Kogyo Co. Ltd. 好中球性炎症疾患の予防および／または治療剤
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
WO2023003497A1 (ru) * 2021-07-23 2023-01-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Соединения с лизосомотропной и противовирусной активностью

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3420851A (en) * 1962-12-19 1969-01-07 Pfizer & Co C Novel dibenzoxepines
US3354155A (en) * 1963-10-14 1967-11-21 Pfizer & Co C Aminoalkylphosphonium compounds and process for the use thereof
JPS4830064B1 (es) * 1968-12-23 1973-09-17
GB1330966A (en) * 1970-12-22 1973-09-19 Yoshitomi Pharmaceutical N-substituted piperidine compounds methods for their production and pharmaceutical compositions containing them
GB1347935A (en) * 1971-04-10 1974-02-27 Yoshitomi Pharmaceutical Piperazine derivatives methods for their production and phar maceutical compositions containing them
JPS5250634B2 (es) * 1971-08-23 1977-12-26
FR2218100A1 (en) * 1973-02-20 1974-09-13 Janssen Pharmaceutica Nv Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones
US4585788A (en) * 1973-09-06 1986-04-29 American Hoechst Corporation 6,11-dihydrodibenz[b,e]oxepin-acetic acids and derivatives
US4282365A (en) * 1978-11-24 1981-08-04 Merck & Co., Inc. Dibenz[b,e]oxepin compounds
JPS58126883A (ja) * 1982-01-25 1983-07-28 Kyowa Hakko Kogyo Co Ltd ジベンゾ〔ｂ，ｅ〕オキセピン誘導体を含有してなる抗喘息剤
JPS6028972A (ja) * 1983-06-29 1985-02-14 Kyowa Hakko Kogyo Co Ltd ジベンゾ［ｂ，ｅ］オキセピン誘導体
JPS6147466A (ja) * 1984-08-10 1986-03-07 Dainippon Pharmaceut Co Ltd アミン誘導体
EP0188802A3 (en) * 1984-12-26 1986-08-20 Kyowa Hakko Kogyo Co., Ltd. Dibenz (b,e) oxepin derivative and antiallergic agent
JPS61152676A (ja) * 1984-12-26 1986-07-11 Kyowa Hakko Kogyo Co Ltd ジベンズ〔ｂ，ｅ〕オキセピン誘導体の製造法
JPS61152673A (ja) * 1984-12-26 1986-07-11 Kyowa Hakko Kogyo Co Ltd ジベンズ〔ｂ，ｅ〕オキセピン誘導体の製造法
JPS61152674A (ja) * 1984-12-26 1986-07-11 Kyowa Hakko Kogyo Co Ltd ジベンズ〔ｂ，ｅ〕オキセピン誘導体の製造法
JPS61152675A (ja) * 1984-12-26 1986-07-11 Kyowa Hakko Kogyo Co Ltd ジベンズ〔ｂ，ｅ〕オキセピン誘導体の製造法
US4596809A (en) * 1985-03-25 1986-06-24 Schering Corporation Substituted 1,8-naphthyridinones, useful as anti-allergic agents
JPS61257981A (ja) * 1985-05-09 1986-11-15 Kyowa Hakko Kogyo Co Ltd ジベンズ〔ｂ，ｅ〕オキセピン誘導体および抗アレルギ−剤
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPH0645600B2 (ja) * 1985-12-25 1994-06-15 大日本製薬株式会社 １，４−ジアザシクロアルカン誘導体
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine

Also Published As

Publication number Publication date
AU612437B2 (en) 1991-07-11
US4994463A (en) 1991-02-19
AU2671188A (en) 1989-06-15
US5302602A (en) 1994-04-12
EP0325755A1 (en) 1989-08-02
US5143922A (en) 1992-09-01
DE3888821T2 (de) 1994-08-11
EP0325755B1 (en) 1994-03-30
DE3888821D1 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
ES2053692T3 (es) Compuestos triciclicos.
BR9912562A (pt) Derivados de pirazol substituìdos condensados com anéis heterocìclicos com seis elementos
ES2152207T3 (es) Derivados condensados de la purina.
MX9205542A (es) Compuesto heterociclico nitrogenado.
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
FI96309B (fi) Menetelmä farmakologisesti arvokkaiden fuusioituneiden polysyklisten yhdisteiden valmistamiseksi
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
ES557198A0 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES2038679T3 (es) Un procedimiento para preparar derivados de dihidrobenzofurano- y cromano-carboxamidas.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ZA867495B (en) Novel polyoxgenated labdane derivatives,processes for their preparation and their use as medicaments
CA2043715A1 (en) Imidazonaphthyridine derivatives
EP0166183A3 (en) Use of hydroxyindole derivatives for lowering the blood pressure
AR041481A1 (es) Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
SE7704829L (sv) Indazolyl-(4)-oxi-propanolaminer
FR2404009A1 (fr) 7-azabenzimidazoles a chaine laterale basique, leur preparation et leurs utilisations therapeutiques
FR2392990A1 (fr) Medicament a base d'un compose heterocyclique bicyclique condense
FR2437405A1 (fr) Nouveaux alcoylbenzenes substitues basiques utiles comme medicaments
ES541698A0 (es) Un procedimiento para preparar nuevos derivados del 1,3-benzo-xatiol.
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
MX9300638A (es) Derivados del acido aminobenzoico.
AR245709A1 (es) Procedimiento para la preparacion de derivados de urea y de carbamato.
ES2062435T3 (es) Nuevas 2-amino-5-ariloximetil-oxazolinas y sus sales.
CO5150171A1 (es) Derivados de higromicina
ES2058641T3 (es) Un procedimiento para preparar un derivado de bifenilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 325755

Country of ref document: ES